Daily Health Headlines

'Artificial Pancreas' Approved for Type 1 Diabetes

👤by Scott Roberts 0 comments 🕔Thursday, September 29th, 2016

WEDNESDAY, Sept. 28, 2016 (HealthDay News) -- The first automated insulin delivery device for type 1 diabetes has been approved by the U.S. Food and Drug Administration for people aged 14 and older.

Often called an "artificial pancreas," the MiniMed 670G hybrid closed loop system automatically monitors blood sugar levels every five minutes and delivers insulin when needed with little or no input from the user, the FDA said in a news release.

"This first-of-its-kind technology can provide people with type 1 diabetes greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin," said Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health.

People with diabetes have an impaired ability to produce or respond to insulin, a blood sugar-regulating hormone normally produced by the pancreas. Type 1 diabetes is often diagnosed in children or young adults.

Clinical testing of the device involved 123 people with type 1 diabetes. No serious adverse reactions were reported. But risks associated with the device include high blood sugar (hyperglycemia), low blood sugar (hypoglycemia), and skin irritation near where the device's sensor attaches to the body, the FDA said.

The product should be considered "unsafe" for use by children aged 6 or younger and for people who require fewer than eight units of insulin daily, the agency said.

As a condition of approval, manufacturer Medtronic Inc. is required to conduct a post-market study to evaluate "how the device performs in real-world settings," the FDA said.

Medtronic, based in Dublin, Ireland, is now studying the device's safety and effectiveness in children aged 7 to 13.

-- Scott Roberts

Article Credits / Source

Scott Roberts / HealthDay

Scott Roberts wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

View More Articles From Scott Roberts 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Diabetes Articles

Low Blood Sugar Linked to Death Risk for Hospital Patients

Low Blood Sugar Linked to Death Risk for Hospital Patients0

THURSDAY, Nov. 17, 2016 (HealthDay News) -- Hospital patients with low blood sugar may be at increased risk for death, a new study from Israel suggests. The study included nearly 3,000 patients with low blood sugar (hypoglycemia). Nearly 32 ...

Can Protein, Probiotics Help With Blood Sugar Control?

Can Protein, Probiotics Help With Blood Sugar Control?0

THURSDAY, Nov. 17, 2016 (HealthDay News) -- Adding protein-rich or probiotic-laden foods to your diet may help control your blood sugar levels, according to a pair of new studies. Both proteins and probiotics appear to slow down digestion of ...

Health Tip: Creating an Insulin Routine

Health Tip: Creating an Insulin Routine0

(HealthDay News) -- If you take insulin, you'll need to create a comfortable routine to keep blood glucose under control. The American Diabetes Association explains: Type 1 diabetes typically needs at least two daily injections of two ...

Daily Can of Soda Boosts Odds for Prediabetes, Study Finds

Daily Can of Soda Boosts Odds for Prediabetes, Study Finds0

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Drinking a can of sugary soda every day can dramatically heighten a person's risk of developing prediabetes, a "warning sign" condition that precedes full-blown type 2 diabetes, a new study reports. A ...

Nearly 6 in 10 Diabetics Skip Eye Exams, Study Finds

Nearly 6 in 10 Diabetics Skip Eye Exams, Study Finds0

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Almost two-thirds of people with diabetes don't get annual eye exams, despite having an increased risk for serious eye disease and vision loss, researchers say. About one in 10 Americans has diabetes. ...

View More Diabetes Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!